Efficiency of Diagnostic Testing for Helicobacter pylori Infections—A Systematic Review
Authors:
- Paula Rojas GarcíaPaula Rojas García
- Simon van der PolSimon van der Pol
- Antoinette D. I. van AsseltAAAntoinette D. I. van Asselt
- Maarten PostmaMPMaarten Postma
- Roberto Rodríguez-IbeasRRRoberto Rodríguez-Ibeas
- Carmelo A. Juárez-CastellóCarmelo A. Juárez-Castelló
- Marino GonzálezMGMarino González
- Fernando AntoñanzasFAFernando Antoñanzas
Open Access
- 8 January 2021
- journal article
- review article
- Published by MDPI AG in Antibiotics
- Vol. 10 (1) , 55
Abstract
Background: The most recommended treatment for a Helicobacter pylori infection is high doses of combined antibiotics. The objective of this article is to perform a systematic review of the economic evaluation studies applied to assess the efficiency of diagnostic testing for H. pylori infections, so that their main characteristics can be identified and to learn from the literature how the antimicrobial resistance (AMR) issue is incorporated into these economic evaluations. Methods: We conducted a systematic review to compare the costs and clinical effectiveness of diagnostic strategies for H. pylori infections. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and extracted the items from the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. Results: We found thirteen articles that were of good quality according to CHEERS: six studies focused on diagnostics of Helicobacter pylori infections associated with dyspepsia and four on duodenal ulcers. Testing was found to be the most cost-effective strategy in eight articles. Four studies considered AMR. Conclusions: Testing was more cost-effective than empirical treatment, except in cases of high prevalence (as with developing countries) or when patients could be stratified according to their comorbidities. The introduction of AMR into the model may change the efficiency of the testing strategy.Keywords
This publication has 44 references indexed in Scilit:
- Bismuth-containing quadruple therapy for Helicobacter pyloriEuropean Journal of Gastroenterology & Hepatology, 2013
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementBMJ, 2013
- Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumptionGut, 2012
- A New Modified Concomitant Therapy for Helicobacter pylori Eradication in TurkeyHelicobacter, 2011
- Cost-effectiveness of six strategies for Helicobacter pyloridiagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice patternBMC Health Services Research, 2010
- Changing Antimicrobial Susceptibility Epidemiology of Helicobacter pylori Strains in Japan between 2002 and 2005Journal of Clinical Microbiology, 2007
- Cost-effectiveness ofHelicobacter pylori“test and treat” for patients with typical reflux symptoms in a population with a high prevalence ofH. pyloriinfection: A Markov model analysisScandinavian Journal of Gastroenterology, 2006
- Cost-effectiveness of a ???score and scope??? strategy for the management of dyspepsiaEuropean Journal of Gastroenterology & Hepatology, 2005
- Recurrent duodenal ulcer haemorrhage: a pharmacoeconomic comparison of various management strategiesExpert Opinion on Pharmacotherapy, 2003
- Evaluation of a novel continuous real time 13C urea breath analyser for Helicobacter pyloriAlimentary Pharmacology & Therapeutics, 2001